Krsnaa Diagnostics Ltd

Krsnaa Diagnostics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Krsnaa Diagnostics Ltd, a small-cap player in the Healthcare Services sector, has exhibited a nuanced shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish trend. Despite a modest day gain of 1.67%, the stock’s broader technical indicators reveal a complex interplay of bullish and bearish signals, underscoring the challenges ahead for investors amid a difficult market backdrop.

Krsnaa Diagnostics Ltd, a small-cap player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. Despite some mixed signals from key technical indicators, the stock’s recent price action and comparative returns against the Sensex highlight ongoing challenges for investors navigating this healthcare services stock.

Krsnaa Diagnostics Ltd, a small-cap player in the Healthcare Services sector, has experienced a nuanced shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish outlook. Despite this slight improvement, the stock continues to face downward pressure, reflected in its recent price action and technical indicators, signalling cautious investor sentiment amid broader market challenges.

Krsnaa Diagnostics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Feb 2026. While the rating change occurred earlier this year, the analysis and financial metrics discussed here reflect the stock’s current position as of 30 May 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Krsnaa Diagnostics Ltd has seen its quality grade downgraded from good to average, reflecting a shift in key business fundamentals. This article examines the underlying factors behind this change, analysing profitability metrics, debt levels, and operational consistency to provide investors with a comprehensive view of the company’s evolving financial health.

Krsnaa Diagnostics Ltd., a small-cap healthcare services provider operating diagnostic centres across India, delivered a remarkable fourth quarter performance in Q4 FY26, with consolidated net profit surging 173.57% quarter-on-quarter to ₹41.72 crores from ₹15.25 crores in Q3 FY26. On a year-on-year basis, the company posted impressive growth of 101.74% compared to ₹20.68 crores in Q4 FY25. However, the stock's subdued market reaction—trading at ₹561.90, down 36.99% from its 52-week high—suggests investors remain cautious about the sustainability of this performance.

Krsnaa Diagnostics Ltd, a small-cap player in the healthcare services sector, has reported a flat financial performance for the quarter ended March 2026, signalling a stabilisation after a period of decline. While the company posted its highest quarterly PAT and EPS to date, other key metrics such as operating profit to interest ratio and profit before tax excluding other income have shown deterioration, reflecting a complex financial landscape for investors to navigate.

Krsnaa Diagnostics Ltd witnessed a robust start to trading on 26 May 2026, opening with a significant gap up of 8.08%, signalling positive market sentiment despite a recent downtrend. The stock outperformed its sector and broader indices, reflecting a notable intraday momentum and heightened volatility.

Krsnaa Diagnostics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Feb 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 19 May 2026, providing investors with an up-to-date perspective on the company’s fundamentals, returns, and market performance.

Krsnaa Diagnostics Ltd has witnessed a notable improvement in its valuation parameters, shifting from a very attractive to an attractive rating, reflecting a more favourable price point relative to its historical and peer benchmarks. Despite ongoing sector headwinds and a challenging market environment, the healthcare services small-cap has demonstrated resilience, though its recent returns lag broader indices.

Krsnaa Diagnostics Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend despite some mildly bullish weekly MACD readings. The stock’s recent downgrade from a Strong Sell to a Sell rating by MarketsMOJO reflects this evolving technical landscape, underscoring challenges ahead for this small-cap healthcare services company.

Krsnaa Diagnostics Ltd, a small-cap player in the Healthcare Services sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish indicators. Despite a recent downgrade in its Mojo Grade to 'Sell' from 'Strong Sell', the stock shows signs of mild bullishness on certain weekly technical parameters, contrasting with persistent bearish trends on monthly and daily charts.

Krsnaa Diagnostics Ltd, a small-cap player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish to a bearish trend. Despite a modest weekly price gain, the stock’s broader technical indicators reveal a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This analysis delves into the recent technical parameter changes and their implications for investors navigating this volatile stock.

Krsnaa Diagnostics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Feb 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 08 May 2026, providing investors with an up-to-date view of its fundamentals, returns, and overall outlook.